Molecular Imaging World Summit 2019
MI—the gateway to precision medicine

Thursday, May 16-Saturday, May 18
Lausanne, Switzerland
Molecular Imaging World Summit 2019
Molecular Imaging World Summit 2019
 
MI Clinical Corner

Hosted by Siemens Healthineers, the Molecular Imaging World Summit 2019 brought together over 240 participants from more than 140 institutions around the world. Featuring 45 speakers, the two-day program included individual talks and panel discussions around the need for quantification and MI’s unique contribution to early diagnosis, planning, and therapy management. A closing session explored possibilities for progressing PET and SPECT imaging. Fueled by optimism for the future, the Summit fostered lively discussion around opportunities for molecular imaging and the field’s significance in the expansion of personalized care.

Scientific Presentations

Opening keynote: Molecular imaging—the gateway to precision medicine: present and future?Prof. John O. Prior, Centre Hospitalier Universitaire Vaudois (Switzerland)

 

Quantification—a pillar for precision medicine

The quantitative origins of PET/CTProf. David Townsend (Ret.), Singapore Clinical Imaging Research Centre (Canada)
Utilizing PET/CT quantification in clinical routineProf. Richard Wahl, Washington University School of Medicine (USA)
SUV values: harmonization and beyondProf. Nicolas Aide, CHU de Caen (France)
Defining thresholds for quantitative SPECT/CT imaging: clinically what is needed and next stepsPanel discussion moderated by Prof. Dale Bailey,
Royal North Shore Hospital (Australia)
Panelists:
Priv.-Doz. Dr. Guido Böning, Ludwig-Maximilians-Universität München (Germany)
Prof. Jun Hatazawa, Osaka University (Japan)
Prof. Homer A. Macapinlac, University of Texas MD Anderson Cancer Center (USA)
Prof. John O. Prior, Centre HospitalierUniversitaireVaudois (Switzerland)
Multiparametric PET—the future?Panel discussion moderated by Dr. Richard E. Carson, Yale University (USA)
Panelists:
Prof. Ronald Borra, University of Groningen, University Medical Center
Groningen (The Netherlands)
Dr. Dustin Osborne, University of Tennessee Graduate School of Medicine (USA)
Dr. Anne M. Smith, Molecular Imaging, Siemens Healthineers (USA)
Prof. Richard Wahl, Washington University School of Medicine (USA)

 

Early diagnosis and planning

Current trends in neurology and the growing demands for imagingDr. Val J. Lowe, Mayo Clinic (USA)
Quantitative 123I and 99mTc SPECT/CT in neurologyProf. Jun Hatazawa, Osaka University (Japan)
Orthopedic view on utilizing SPECT/CT in clinical practiceDr. Helmut Rasch, Kantonsspital Baselland (Switzerland)
Our experience using xSPECT/CT bone in musculoskeletal medicineDr. Iain Duncan, Garran Medical Imaging (Australia)
Efficiency by routine: MSK xSPECT/CTDrs. Human Adams, Green Heart Hospital (The Netherlands)
Possible applications for xSPECT QuantProf. Damian Wild, Universitätsspital Basel (Switzerland)
Early detection and treatment of cardiovascular disease: the future and what’s neededDr. Venkatesh Murthy, University of Michigan, Ann Arbor (USA)
Biograph Vision—clinical experience and potentialPanel discussion moderated by Dr. Daniel A. Pryma,
University of Pennsylvania Perelman School of Medicine (USA)
Panelists:
Dr. Walter Noordzij, University of Groningen,
University Medical Center Groningen (The Netherlands)
Prof. John O. Prior, Centre HospitalierUniversitaireVaudois (Switzerland)
Prof. Pierre-Yves Salaün, University Hospital Brest (France)
syngo.via for Molecular Imaging as a tool for therapy and prognosis assessmentProf. Elba Cristina Sá de Camargo Etchebehere, The University of Campinas and grupoMND (Brazil)

 

Therapy management

Radionuclide therapy: standardized or personalized?Prof. Rodney Hicks, Peter MacCallum Cancer Centre (Australia)
Bringing nuclear medicine to patients
An industry perspective
Dr. GermoGericke, Advanced Accelerator Applications, A Novartis Company (Switzerland)
Advanced therapy and imaging in metastatic prostate cancerProf. Dr. Alexander Drzezga, UniklinikKöln (Germany)
Quantitative SPECT/CT imaging for therapies: from response assessment to dose tailoring today and beyondPanel discussion moderated by Prof. Dale Bailey, Royal North Shore Hospital (Australia)
Panelists:
Prof. Dr. Peter Bartenstein, Ludwig-Maximilians-Universität München (Germany)
Dr. Jean-Mathieu Beauregard, CHU de Québec -UniversitéLaval (Canada)
Dr. GermoGericke, Advanced Accelerator Applications, A Novartis Company (Switzerland)
Prof. Rodney Hicks, Peter MacCallum Cancer Centre (Australia)
Prof. Niklaus Schaefer, Centre HospitalierUniversitaireVaudois (Switzerland)
Prof. Damian Wild, UniversitätsspitalBasel (Switzerland)
Precision immuno-oncology and molecular imaging opportunitiesProf. Olivier Michielin, Centre Hospitalier Universitaire Vaudois (Switzerland)
PET imaging for immunotherapyProf. Wolfgang A. Weber, Technische Universität München (Germany)
Shanghai Zhongshan Hospital Nuclear Medicine Department A glimpse into molecular imaging development in ChinaProf. Dr. Shi Hongcheng, Zhongshan Hospital, Fudan University (China)

 

Progressing molecular imaging

Value of short-interval whole-body dynamic FDG-PET using Biograph Horizon Flow editionProf. Nagara Tamaki, KyotoPrefecturalUniversityofMedicine (Japan)
Dr. Bernard Bendriem, Molecular Imaging, Siemens Healthineers (USA)
Respiratory gating in PETL current status and the future of motion managementProf. Dr. Klaus Schäfers, Universitätsklinikum Münster (Germany)
Paul Schleyer, Molecular Imaging, Siemens Healthineers (USA)
FAPI-ligands: a new oncological imaging probe in PET/CTProf. Dr. F. L. Giesel, University Hospital Heidelberg (Germany)
Considerations for quantitative cardiac SPECT/CT and
coronary CTA/CT-FFR
Dr. Venkatesh Murthy, University of Michigan, Ann Arbor (USA)
Alexander Hans Vija, Molecular Imaging, Siemens Healthineers (USA)
Opportunities for AI in molecular imagingUniv.-Prof. Dr. Marcus Hacker, MedizinischenUniversität Wien (Austria)
Sven Zuehlsdorff, Molecular Imaging, Siemens Healthineers (USA)
Looking ahead: future molecular imaging centersProf. Martin Alexander Walter, Hôpitaux Universitaires de Genève (Switzerland)